Trials / Conditions / Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
4 registered clinical trials studyying Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukem NCT07194980 | Fred Hutchinson Cancer Center | Phase 2 |
| Recruiting | Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minoritie NCT06859008 | City of Hope Medical Center | Phase 1 |
| Terminated | Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Stu NCT04230304 | Mayo Clinic | Phase 2 |
| Completed | Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT02960646 | M.D. Anderson Cancer Center | Phase 1 |